FDA Inspection 923526 — K.C. Pharmaceuticals, Inc

K.C. Pharmaceuticals, Inc — FEI 2026940

The FDA completed an inspection of K.C. Pharmaceuticals, Inc on March 19, 2015 in Pomona, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 19, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pomona, CA (United States)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
145121 CFR 211.113(b)Procedures for sterile drug products
150521 CFR 211.122(d)Label storage access limited to authorized personnel
364021 CFR 211.204Returned drug products identified and held
434221 CFR 211.142(b)Storage under appropriate conditions
440221 CFR 211.192Written record of investigation incomplete